A contribution to safety assessment of veterinary drug residues: in vitro / ex vivo studies on the intestinal toxicity and transport of covalently bound residues

References

• BORENFREUND, E. and PUERNER, J., 1985, Toxicity determined in vitro by morphological alteration and neutral red absorption. Toxicology Letters, 24, 119–224.
   PubMed Web of Science ®Google Scholar
• DE ANGELIS I., HOOGENBOOM, L. A. P., HUVENEERS -0ORSPRONG, M. B. M., Zucco, F. and STAMMATI A., 1994, Established cell lines for safety assessment of food contaminants: differing furazolidone toxicity to V79, HEp-2 and Caco-2 cells. Food and Chemical Toxicology, 32, 481–488.
   Google Scholar
• DELIE, F. and RUBAS, W., 1997, A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Critical Reviews in Therapeutic Drug Carrier Systems, 14, 221–286.
   PubMed Web of Science ®Google Scholar
• FISHER, R. B. and GARDNER, M. L. G., 1974, A kinetic approach to the study of solutes by isolated perfused small intestine. Journal of Physiology, 241, 211–234.
   PubMedGoogle Scholar
• FOGH, J., FOGH, J. M. and ORFEO, T., 1977, One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice. Journal of the National Cancer Institute, 59, 221–226.
   PubMed Web of Science ®Google Scholar
• GRASSET, E., PINTO, M., DUSSAULX, E., ZWEIBAUM, A. and DESJEUX, J. F., 1984, Epithelial properties of human colonic carcinoma cell line Caco-2 : electrical parameters. American Journal of Physiology, 247, C260–267.
   PubMed Web of Science ®Google Scholar
• GRASSET, E., BERNAREU, J. and PINTO, M., 1985. Epithelial properties of human colonic carcinoma cell line (Caco-2): effect of secretagogues. American Journal of Physiology, 248, C410-418. GUENGERICH, F. P., 1989, Analysis and characterisation of enzymes. In W. Hayes (ed.), Principles and Methods of Toxicology (New York: Raven), pp. 784–785.
   Google Scholar
• HOOGENBOOM, L. A. P., VAN KAMMEN M., BERGHMANS, M. C. J., KOEMAN, J. H. and KUIPER, H. A., 1991, The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone. Food and Chem/Cal Toxicity, 29, 321–328.
   Google Scholar
• HOOGENBOOM, L. A. P., BERGHMANS, M. C. J., POLMAN, T. H. G., PARKER, R. and SHAW, I. C., 1992, Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side chain from liver, kidney, and muscle tissue from pigs. Food Additives and Contaminants, 9, 623–630.
   Google Scholar
• HORNE, E., CADOGAN, A., O'KEEFE, M. and HOOGENBOOM, L. A. P., 1996, Analysis of protein-bound metabolites of furazolidone and furaltadone in pig liver by high-performance liquid chromato-graphy with UV and mass spectrometric detection. Proceedings of the EuroResidue III Conference, 1,510–515.
   Google Scholar
• KLEE, S., UNGEMACH, F. R. and KROKE R., 1992, Fate of furazolidone in the isolated perfused gut and in isolated intestinal cells. Acta V eterinaria Scandinavica, 87 (suppl.), 452–453.
   Google Scholar
• KLUGE, K., KLEE, S. and UNGEMACH, F. R., 1996, Studies on the covalent binding of furazolidone to liver microsomes. Naunyn Schmiedeberg's Archives of Pharmacology, 253 (suppl.), R10.
   Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. and RANDALL, R. J., 1951, Protein measurements with the Folin reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MEUNIER, V., BOURRIE, M., BERGER, Y. and FABRE, G., 1995, The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biology and Toxicology, 11, 187–194.
   PubMed Web of Science ®Google Scholar
• PAUL, H. E. and PAUL, M. F., 1964, The nitrofurans — chemotherapeutic properties. In R. J. Schnitzer and F. Hawking (eds), Experimental Chemotherapy, vol. 2 (New York: Academic Press), pp. 307–370.
   Google Scholar
• PINTO, M., ROBINE -LEON, S., APPAY, M. D., KEDINGER, M., TRIADOU, N., DUSSAULX, E., LACROIX, B., SuvioN -ASSMAN, P., HAFFEN, K., FOGH, J. and ZWEIBAUM, A., 1983, Enterocyte-like differentiation and polarisation of the human colon carcinoma cell line Caco-2 in culture. Biology of the Cell, 47, 323–330.
   Google Scholar
• RANALDI, G., ISLAM, K. and SAMBU Y., 1992, Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents. Antimicrobial Agents and Chemotherapy, 36, 1374–1381.
   PubMed Web of Science ®Google Scholar
• RICHTER, E. and STRUGALA, G. J., 1985, An all-glass perfusator for investigation of the intestinal transport and metabolism of foreign compounds in vitro. Journal of Pharmacological Methods, 14, 297–304.
   PubMedGoogle Scholar
• RICO, A. G. and BURGAT-SACAZE, V., 1984, Toxicological significance of covalently bound residues. Food Additives and Contaminants, 1, 157–161.
   Google Scholar
• TATSUMI, K., NAKABEPPU H., TAKAHASHI, S. and KITAMURA, S., 1984, Metabolism in vivo of furazolidone: evidence for formation of an open-chain carboxylic acid and ketoglutaric acid from the nitrofuran in rats. Archives of Biochemistry and Biophysics, 234, 112–116.
   Google Scholar
• VilAm, A., 1990, Definition of bound residues. Drug Metabolism Reviews, 22, 591–593.
   PubMedGoogle Scholar
• VROOMEN, L. H. M., BERGHMANS, M. C. J., VAN LEEUWEN, P., VAN DER STRUIJS, T. D. B., DE VRIES, P. H. U. and KUIPER, H. A., 1986, Kinetics of ' C-furazolidone in piglets upon oral administration during 10 days and its interaction with tissue macromolecules. Food Additives and Contaminants, 3, 331–346.
   Google Scholar
• VROOMEN, L. H. M., BERGHMANS, M. C. J., HEKMAN, P., HOOGENBOOM, L. A. P. and KUIPER, H. A., 1987a, The elimination of furazolidone and its open-chain cyanoderivative from adult swine. Xenobiotka, 17, 1427–1435.
   Google Scholar
• VROOMEN, L. H. M., GROTEN J. P., VAN MUISWINKEL, K., VAN VELDHUIZEN, A. and VAN BLADEREN P. J., 1987b, Identification of a reactive intermediate of furazolidone formed by swine liver microsomes. Toxicology In vitro, 1, 97–104.
   Google Scholar
• VROOMEN, L. H. M., BERGHMANS, M. C. J., VAN BLADEREN, P. J., GROTEN J. P., WISSINK, C. J. and KUIPER, H. A., 1990, In vivo and in vitro metabolic studies of furazolidone: a risk evaluation. Drug Metabolism Reviews, 22, 663–676.
   Google Scholar
• WEBER, N. E., 1992, Bound residues — safety testing and risk assessment. In H. A. Kuiper and L. A. P. Hoogenboom (eds), Proceedings of the Workshops, Ghent, 22–24 May 1992 and Thessaloniki, 30–31 October 1992 (Wageningen: State Institute for Quality Control of Agricultural Products (RIKILT-DLO)).
   Google Scholar
• WENTGES H., KLEE, S., UNGEMACH, F. R. and POSPISCHIL, A., 1991, Influence of different solvents on the functionality and viability of the isolated perfused gut. Naunyn-Schmiedeberg's Archives of Pharmacology, 344 (suppl.), 33.
   Google Scholar